We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current MEDS market cap is 7.47M. The company's latest EPS is USD -3.2448 and P/E is -1.91.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 2.4M | 2.53M | 2.25M | 2.25M | 1.42M |
| Operating Income | -407k | -1.95M | -348k | -345k | -378k |
| Net Income | -563k | -1.3M | -678k | -1.98M | -3.48M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 3.83M | 7.44M | 17.12M | 9.89M | 11.45M |
| Operating Income | -87k | 125k | -2.51M | -5.29M | -4.43M |
| Net Income | 9k | -284k | -2.54M | -5.32M | -3.91M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 4.69M | 3.71M | 4.04M | 3.75M | 21.65M |
| Total Liabilities | 3.33M | 3.37M | 3.38M | 5.04M | 10.09M |
| Total Equity | 1.36M | 343k | 655k | -1.3M | 11.56M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 2.23M | 5.57M | 9.79M | 5.77M | 3.71M |
| Total Liabilities | 1.38M | 1.43M | 1.11M | 2M | 3.37M |
| Total Equity | 845k | 4.14M | 8.68M | 3.77M | 343k |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -2.76M | -1.53M | -931k | -603k | -1.21M |
| Investing | -313k | -428k | 333k | 282k | 74k |
| Financing | 268k | -35k | 681k | -44k | 71k |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 273k | 142k | -2.22M | -2.57M | -1.53M |
| Investing | -265k | -332k | -38k | -23k | -428k |
| Financing | 678k | 2.19M | 5.3M | -208k | -35k |
| Market Cap | 7.47M |
| Price to Earnings Ratio | -1.91 |
| Price to Sales Ratio | 0.65 |
| Price to Cash Ratio | 6.59 |
| Price to Book Ratio | 21.78 |
| Dividend Yield | 129.03% |
| Shares Outstanding | 1.21M |
| Average Volume (1 week) | 29.68k |
| Average Volume (1 Month) | 29.49k |
| 52 Week Change | 29.09% |
| 52 Week High | 44.56 |
| 52 Week Low | 3.69 |
| Spread (Intraday) | 0.42 (6.58%) |
| Company Name | TRxADE HEALTH Inc |
| Address |
850 new burton road dover, delaware 19904 |
| Website | https://www.trxadehealth.com |
| Industry | drugs and proprietary-whsl (5122) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
